These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4582551)

  • 1. [Differential diagnosis. Visual anomalies in schizophrenics and persons with organic brain damage (author's transl)].
    Schlegel P
    Arch Psychiatr Nervenkr (1970); 1973 Jul; 217(3):271-84. PubMed ID: 4582551
    [No Abstract]   [Full Text] [Related]  

  • 2. DIfferentiation of organics from schizophrenics with Reitan's sensory-perceptual disturbances tests.
    Watson CG; Thomas RW; Felling J; Andersen D
    Percept Mot Skills; 1968 Jun; 26(3):Suppl:1191-8. PubMed ID: 5675686
    [No Abstract]   [Full Text] [Related]  

  • 3. Differentiation of schizophrenics with and without brain damage using the Whitaker Index of Schizophrenic Thinking.
    Puente AE; Sanders CH
    J Clin Psychol; 1981 Jul; 37(3):464-6. PubMed ID: 7263870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationships between disorders of visual perception and unilateral spatial neglect.
    Gainotti G; Tiacci C
    Neuropsychologia; 1971 Dec; 9(4):451-8. PubMed ID: 5164380
    [No Abstract]   [Full Text] [Related]  

  • 5. Cognitive and perceptual differences between schizophrenics and organics.
    Goldstein G
    Schizophr Bull; 1978; 4(2):160-85. PubMed ID: 746370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The diagnostic and prognostic significance of disorders of conceptive thinking in schizophrenic patients (author's transl)].
    Stanikowska I
    Psychiatr Pol; 1981; 15(3):279-84. PubMed ID: 7029587
    [No Abstract]   [Full Text] [Related]  

  • 7. Objective Draw-a-Person scales: an attempted cross-validation.
    Watson CG; Felling J; Maceachern DG
    J Clin Psychol; 1967 Jul; 23(3):382-6. PubMed ID: 4866661
    [No Abstract]   [Full Text] [Related]  

  • 8. Lateralized anomalous perceptual experiences in schizophrenia.
    Persaud R; Cutting J
    Psychopathology; 1991; 24(6):365-8. PubMed ID: 1780430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance characteristics of chronic schizophrenia on attention tests sensitive to unilateral brain damage.
    Mizuno M; Kato M; Sartori G; Okawara H; Kashima H
    J Nerv Ment Dis; 1997 Jul; 185(7):427-33. PubMed ID: 9240360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of brain-damage in schizophrenics as measured by the Whitaker Index of Schizophrenic Thinking and the Luria-Nebraska Neuropsychological Battery.
    Puente AE; Heidelberg-Sanders C; Lund N
    Percept Mot Skills; 1982 Apr; 54(2):495-9. PubMed ID: 7079075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnosis and understanding of schizophrenia. Part III. Speculations on the processes that underlie schizophrenic symptoms and signs.
    Strauss JS; Carpenter WT; Bartko JJ
    Schizophr Bull; 1974; (11):61-9. PubMed ID: 4469362
    [No Abstract]   [Full Text] [Related]  

  • 12. The separation of NP hospital organics from schizophrenics with three visual motor screening tests.
    Watson CG
    J Clin Psychol; 1968 Oct; 24(4):412-4. PubMed ID: 5735097
    [No Abstract]   [Full Text] [Related]  

  • 13. Concept identification and practice in brain-damaged and process-reactive schizophrenic groups.
    Parsons OA; Klein HP
    J Consult Clin Psychol; 1970 Dec; 35(3):317-23. PubMed ID: 5489467
    [No Abstract]   [Full Text] [Related]  

  • 14. Relative efficacy of the Sc-O, P-O, P-N, and Sc MMPI scales in differentiating brain-damaged, brain-damaged schizophrenic, schizophrenic, and somatoform disorders in an outpatient setting.
    Puente AE; Rodenbough J; Horton AM
    J Clin Psychol; 1989 Jan; 45(1):99-105. PubMed ID: 2925890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive-perceptual abilities of a neurologically impaired infant: an alternative assessment strategy.
    Byrne JM
    Dev Med Child Neurol; 1984 Jun; 26(3):391-5. PubMed ID: 6734956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parameters of the spiral after-effect in organics, schizophrenics, and normals.
    Hersen M; Levine J; Church A
    J Genet Psychol; 1972 Jun; 120(2d Half):177-87. PubMed ID: 5066579
    [No Abstract]   [Full Text] [Related]  

  • 17. Schizophrenic subgroups with normal and abnormal cognitive functioning on the Luria-Nebraska Neuropsychological Battery.
    Moses JA
    Int J Neurosci; 1983 Oct; 21(1-2):129-35. PubMed ID: 6671868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of organics from schizophrenics with the trail making, dynamometer, critical flicker fusion, and light-intensity matching tests.
    Watson CG; Thomas RW; Felling J; Andersen D
    J Clin Psychol; 1969 Apr; 25(2):130-3. PubMed ID: 5789196
    [No Abstract]   [Full Text] [Related]  

  • 19. Adherence to strong verbal meaning definitions in schizophrenics.
    Neuringer C; Fiske JP; Schmidt MW; Goldstein G
    J Genet Psychol; 1972 Dec; 121(2d Half):315-23. PubMed ID: 4650428
    [No Abstract]   [Full Text] [Related]  

  • 20. Rotations of visual designs in psychopathological groups.
    Royer FL; Holland TR
    J Consult Clin Psychol; 1975 Aug; 43(4):546-56. PubMed ID: 1159153
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.